Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT03586232

Arnica Montana and Bromelain in Rhinoplasty

Effects of Arnica Montana and Bromelain in Rhinoplasty

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Boston Medical Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to assess the perioperative use of Arnica Montana and the combined use of Arnica Montana and Bromelain in aiding the body's wound healing functions during the postoperative period after rhinoplasty. The secondary objective of the study is to determine if there is a reduction in postoperative edema when Arnica Montana and Bromelain are combined. Another secondary objective is to demonstrate increased patient satisfaction with the use of Arnica Montana and the combination Arnica Montana and Bromelain.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTArnica MontanaArnica Montana is from the Asteraceae plant family and is native to the mountain areas in Europe and western North America. It is reported to have anti-inflammatory, antiseptic, and vasodilatory properties and is often used in plastic surgery to help reduce pain, edema, and ecchymosis postoperatively.
DIETARY_SUPPLEMENTBromelainBromelain is a protease enzyme derived from the pineapple plant, Ananas comosus, which has been used to reduce swelling, inflammation, and pain and may help to reduce wound healing time.
OTHERPlaceboA pharmacologically inert preparation

Timeline

Start date
2019-08-01
Primary completion
2020-08-01
Completion
2020-08-01
First posted
2018-07-13
Last updated
2019-08-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03586232. Inclusion in this directory is not an endorsement.